4.8 Article

A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Salim S. Virani et al.

Summary: The 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease updates and consolidates previous guidelines and provides evidence-based approaches to patient management, taking into account social determinants of health and emphasizing shared decision-making and team-based care. It covers various aspects, including treatment decisions, symptom reduction, revascularization, special populations, follow-up and monitoring, evidence gaps, and areas for future research.

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial

Alexandra N. Nowbar et al.

Summary: This study aims to assess the placebo-controlled efficacy of PCI on angina frequency in patients with single- or multivessel disease. Participants will discontinue antianginal therapy, record symptoms using a smartphone application, and undergo various assessments and tests to evaluate primary and secondary outcomes.

EUROINTERVENTION (2022)

Article Cardiac & Cardiovascular Systems

Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR

Sashiananthan Ganesananthan et al.

Summary: Smart devices play a crucial role in acquiring, processing, storing, and transferring digital health data in clinical trials. However, current trials investigating angina and other interventions do not accurately consider patient-centered outcomes and the nature of angina symptoms. This article discusses the benefits, challenges, and limitations of incorporating smart devices into clinical trials, using our research group's experience in trials for stable coronary artery disease as an example. The authors hope that this approach will provide a more comprehensive understanding of the impact of angina on patients' lives.

EUROPEAN HEART JOURNAL SUPPLEMENTS (2022)

Article Cardiac & Cardiovascular Systems

Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

Michael Foley et al.

Summary: In the ORBITA trial, successful optimization of medical therapy was achieved through a 6-week intensive treatment period for 200 patients, with minimal drug adverse effects leading to therapy cessation.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Medicine, General & Internal

Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)

David J Beard et al.

LANCET (2020)

Article Medicine, General & Internal

Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease

John A. Spertus et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Initial Invasive or Conservative Strategy for Stable Coronary Disease

David J. Maron et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Cardiac & Cardiovascular Systems

Sham-Controlled Trials for Coronary Interventions Ethically Acceptable and Ethically Important

Neal W. Dickert et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease

Manesh R. Patel et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Mathematical & Computational Biology

Modeling continuous response variables using ordinal regression

Qi Liu et al.

STATISTICS IN MEDICINE (2017)

Editorial Material Cardiac & Cardiovascular Systems

Overcoming the three biases obscuring the science of renal denervation in humans: Big-day bias, check-once-more bias and I-will-take-it-now bias

James P. Howard et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2015)

Article Medicine, General & Internal

Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease

Bernard De Bruyne et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Optimal medical therapy with or without PCI for stable coronary disease

William E. Boden et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Cardiac & Cardiovascular Systems

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

BR Chaitman et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)

Article Medicine, Research & Experimental

Assessment of blinding in clinical trials

HJ Bang et al.

CONTROLLED CLINICAL TRIALS (2004)